Histone deacetylase inhibitors in cancer therapy: Is transcription the primary target?

被引：409
|
作者：
Johnstone, RW
Licht, JD
机构：
[1] Mt Sinai Sch Med, New York, NY 10029 USA
[2] Peter MacCallum Canc Ctr, Melbourne, Vic 3002, Australia
来源：
CANCER CELL | 2003年 / 4卷 / 01期
关键词：
D O I：
10.1016/S1535-6108(03)00165-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：13 / 18
页数：6
相关论文
共 50 条
  • [21] Histone Deacetylase Inhibitors: An Attractive Strategy for Cancer Therapy
    Li, Jiyang
    Li, Guangqiang
    Xu, Wenqing
    CURRENT MEDICINAL CHEMISTRY, 2013, 20 (14) : 1858 - 1886
  • [22] Potential of histone deacetylase inhibitors for the therapy of ovarian cancer
    Guo, Fengyi
    Wang, Hongjing
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [23] Histone deacetylase inhibitors that target tubulin
    Schemies, Joerg
    Sippl, Wolfgang
    Jung, Manfred
    CANCER LETTERS, 2009, 280 (02) : 222 - 232
  • [24] Kinase and Histone Deacetylase Hybrid Inhibitors for Cancer Therapy
    Luan, Yepeng
    Li, Jerry
    Bernatchez, Jean A.
    Li, Rongshi
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (07) : 3171 - 3183
  • [25] Discovery of Novel Dual Histone Deacetylase and Mammalian Target of Rapamycin Target Inhibitors as a Promising Strategy for Cancer Therapy
    Chen, Yong
    Yuan, Xue
    Zhang, Wanhua
    Tang, Minghai
    Zheng, Li
    Wang, Fang
    Yan, Wei
    Yang, Shengyong
    Wei, Yuquan
    He, Jun
    Chen, Lijuan
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (03) : 1577 - 1592
  • [26] Histone deacetylase inhibitors in programmed cell death and cancer therapy
    Marks, PA
    Jiang, XJ
    CELL CYCLE, 2005, 4 (04) : 549 - 551
  • [27] Multi-Targeted Histone Deacetylase Inhibitors in Cancer Therapy
    Ai, T.
    Cui, H.
    Chen, L.
    CURRENT MEDICINAL CHEMISTRY, 2012, 19 (04) : 475 - 487
  • [28] Liposomes loaded with histone deacetylase inhibitors for breast cancer therapy
    Urbinati, Giorgia
    Marsaud, Veronique
    Plassat, Vincent
    Fattal, Elias
    Lesieur, Sylviane
    Renoir, Jack-Michel
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2010, 397 (1-2) : 184 - 193
  • [29] Nanotechnology-Based Histone Deacetylase Inhibitors for Cancer Therapy
    Tu, Bin
    Zhang, Meng
    Liu, Tuanbing
    Huang, Yongzhuo
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2020, 8
  • [30] Histone deacetylase inhibitors open new doors in cancer therapy
    McLaughlin, F
    La Thangue, NB
    BIOCHEMICAL PHARMACOLOGY, 2004, 68 (06) : 1139 - 1144
12345